- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Drug Delivery Systems
IntelliPharmaCeutics International Inc/CA
+ Add to WatchlistIPCI:US
1.7700 USD 0.0100 0.56%As of 20:10:00 ET on 05/17/2013.
Snapshot for IntelliPharmaCeutics International Inc/CA (IPCI)
| Open: | 1.7600 | Day's Range: | 1.7600 - 1.8120 | Volume: | 6,370 |
|---|---|---|---|---|---|
| Previous Close: | 1.7700 | 52wk Range: | 1.5700 - 3.4900 | 1-Yr Rtn: | -39.80% |
Key Statistics for IPCI
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(11/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | - |
| Est. EPS (USD) (11/2013) | -0.3370 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 34.91 |
| Shares Outstanding (M) | 19.72 |
| 30 Day Average Volume | 30,029 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/03/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for IPCI
Company Profile & Key Executives for IPCI
IntelliPharmaCeutics International Inc. develops drug delivery technologies. The Company has developed a controlled release drug delivery platform to provide life cycle management or new chemical entity delivery system solutions for virtually any small molecule.
| Isa OdidiChairman/CEO/Co-Founder | Amina OdidiPresident/COO |
| Shameze RampertabVP:Finance/CFO | John Newell AllportVP:Legal Affairs & Licensing |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
IPCI News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page